A 3-Carboxy-3-hydroxypentane-1,5-dioic acid CEP of the European Pharmacopoeia monograph is often referred to as a 3-Carboxy-3-hydroxypentane-1,5-dioic acid Certificate of Suitability (COS). The purpose of a 3-Carboxy-3-hydroxypentane-1,5-dioic acid CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 3-Carboxy-3-hydroxypentane-1,5-dioic acid EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 3-Carboxy-3-hydroxypentane-1,5-dioic acid to their clients by showing that a 3-Carboxy-3-hydroxypentane-1,5-dioic acid CEP has been issued for it. The manufacturer submits a 3-Carboxy-3-hydroxypentane-1,5-dioic acid CEP (COS) as part of the market authorization procedure, and it takes on the role of a 3-Carboxy-3-hydroxypentane-1,5-dioic acid CEP holder for the record. Additionally, the data presented in the 3-Carboxy-3-hydroxypentane-1,5-dioic acid CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 3-Carboxy-3-hydroxypentane-1,5-dioic acid DMF.
A 3-Carboxy-3-hydroxypentane-1,5-dioic acid CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 3-Carboxy-3-hydroxypentane-1,5-dioic acid CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 3-Carboxy-3-hydroxypentane-1,5-dioic acid suppliers with CEP (COS) on PharmaCompass.